Skip to content

Effect of Coughing Technique, ShotBlocker, and Vibration on Pain and Satisfaction During Subcutaneous Insulin Injections for Adults Patients with Type 2 Diabetes mellitus: A Randomized Controlled Trial

Effect of Coughing Technique, ShotBlocker, and Vibration on Pain and Satisfaction During Subcutaneous Insulin Injections for Adults Patients with Type 2 Diabetes mellitus: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241103063580N1
Enrollment
124
Registered
2024-12-02
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes mellitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Those possessing the eligible card will select from one of four distinct colored cards, each symbolizing a unique intervention condition: Yellow for the coughing te

Sponsors

College of nursing ,University of Baghdad
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participants must be adults diagnosed with Type 2 diabetes currently hospitalized Aged 18 years or older Alert, and capable of providing informed consent Participants should demonstrate the ability to comprehend and adhere to verbal instructions Be undergoing regular subcutaneous insulin injections Not have administered any analgesic medications for a minimum duration of 8 hours prior to the injection.

Exclusion criteria

Exclusion criteria: Patients diagnosed with Type 2 diabetes for a duration of 10 years or more Suffered trauma near the injection site Patients exhibiting cognitive impairments or mental health disorders that hinder their capacity to understand or provide consent Patients presenting with active infections or complications at the injection site

Design outcomes

Primary

MeasureTime frame
The primary outcome variable is the level of pain that can be changed. based on Vibration or coughing technique or ShotBlocke. Timepoint: for 2-3 seconds before needle insertion. immediately after subcutaneous insulin injection when using the ShotBlocker, vibration device, and coughing technique. The level of pain will be measured. Method of measurement: Visual Analogue Scale (VAS).

Secondary

MeasureTime frame
The secondary outcome variable is the level of patient satisfaction that can be changed based on vibration device or coughing techniqe or shotblocker. Timepoint: for 2-3 seconds before needle insertion. immediately after subcutaneous insulin injection when using the ShotBlocker, vibration device, and coughing technique.the level of satisfaction will be measured. Method of measurement: Visual Individual Satisfaction Scale (VISS).

Countries

Iraq

Contacts

Public ContactAli DHAHIR Abdul yemmah

College of nursing,University of Baghdad

ali.abd2302m@conursing.uobaghdad.edu.iq+964 1 415 0076

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026